Published 2005 | Version v1
Miscellaneous

The synthesis of isotopic fluorine and iodine-labeled COX-II inhibitor and in vitro validation

  • 1. Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of)

Description

In these day, NASIDs (non-steroidal antiinflammatory drugs) such as aspirin, diclofenac and ibuprofen are the most common medications used to reduce pain and inflammation. However, they act by inhibiting both COX-I and COX-II which can cause serious gastrointestinal side effects such as ulcers, stomach perforations and bleeds. COX-I produces prostaglandins believed to be responsible for the protection of the stomach lining. However, COX-II produces prostaglandins believed to be responsible for pain and inflammation. Recently, the most widely studied selective COX-II inhibitor such as celecoxib and rofecoxib' one work by inhibiting the effect of COX-II on pain and inflammation without inhibiting COX-I which protects gastrointestinal lining

Part of:
Proceedings of the KNS spring meeting

Additional details

Publishing Information

Publisher
KNS
Imprint Place
Taejon (Korea, Republic of)
Imprint Title
Proceedings of the KNS spring meeting
Imprint Pagination
[1 CD-ROM]
Journal Page Range
[2 p.]

Conference

Title
2005 spring meeting of the KNS
Dates
26-27 May 2005
Place
Jeju (Korea, Republic of)

INIS

Country of Publication
Korea, Republic of
Country of Input or Organization
Korea, Republic of
INIS RN
37041805
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference, Non-conventional Literature
Descriptors DEI
FLUORINE ISOTOPES; IN VITRO; RADIOPHARMACEUTICALS; SYNTHESIS; VALIDATION
Descriptors DEC
DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; RADIOACTIVE MATERIALS; TESTING

Optional Information

Notes
2 refs, 5 figs, 1 tab